Company Overview
PharmaCyte Biotech is a biotechnology company developing cellular therapies for cancer and diabetes based upon a proprietary cellulose-based live cell encapsulation technology known as “Cell-in-a-Box®.” This technology will be used as a platform upon which therapies for several types of cancer and diabetes are being developed.
Recent News
PharmaCyte Biotech Initiates Studies to Confirm Its Pancreatic Cancer Therapy Can Treat Malignant Ascites
Stock Overview
05/26/2022 04:00 PM EDT
Investor Relations
PharmaCyte Biotech, Inc.
Investor Relations Department
T: 917-595-2856
Info@PharmaCyte.com